why choose us

First received: January 04, 2023

Clinical Trial: A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Mature B-cell Neoplasms

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Clinical Study of Nemtabrutinib (MK-1026) in Japanese Participants With Hematological Malignancies (BELLWAVE-002)

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of nemtabrutinib in Japanese participants with mature B-cell neoplasms.

Read more